NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

What is likely happening here is that NHS has looked at all of DCVax-L's data and concluded that they need to get this treatment to its citizenry NOW.

The NHS didn't look at any DCVAXL data thats the MHRA's job. Good grief, basic biotech due diligence. The NHS consulted with the MHRA, which gave the green light and then they went ahead and provided IFR as a first stop before general funding. This is great new because in the history of EMA and MHRA its has never been so that following an IFR funding a drug was then dismissed for approval by the MHRA.